The negative-strand RNA viruses are a broad group of animal viruses that comprise several important human pathogens, including influenza, measles, mumps, rabies, respiratory syncytial, Ebola, and hantaviruses. The development of new strategies to genetically manipulate the genomes of negative-strand RNA viruses has provided us with new tools to study the structure-function relationships of the viral components and their contributions to the pathogenicity of these viruses. It is also now possible to envision rational approaches-based on genetic engineering techniques-to design live attenuated vaccines against some of these viral agents. In addition, the use of different negative-strand RNA viruses as vectors to efficiently express foreign polypeptides has also become feasible, and these novel vectors have potential applications in disease prevention as well as in gene therapy.
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DNA-Containing Viruses
Among animal viruses, DNA-containing viruses were the first to become amenable to genetic engineering techniques. This breakthrough was achieved for simian virus 40 when a cloned cDNA copy was transfected into cells, resulting in the formation of infectious virus (see Table 1 ). Transfected mutated cDNA molecules gave rise to defined mutant viruses (1) . A second methodology involving the use of homologous recombination allowed, for the first time, the rescue of large DNAcontaining viruses such as herpes viruses (2) . In this approach, intact herpes viral DNA as well as cloned DNA flanked by viral sequences was transfected into cells. Homologous recombination between the cloned DNA and the wild-type genome can occur, and novel viruses can be selected under appropriate conditions. For example, recombinants with DNA fragments containing a viral thymidine kinase gene can be selected in appropriate cell lines and media, and viruses lacking a thymidine kinase can be isolated in the presence of nucleoside analogs (e.g., Ara T). This general technique allows the successful construction of viral variants of herpes viruses, and similar procedures have been developed for pox viruses (3, 4) and other DNA-containing viruses including adenoviruses (5) and parvoviruses (6) . Finally, strategies have been developed to generate infectious as well as mutant viruses by transfecting cosmids containing overlapping portions of large viral genomes. Viruses arise via recombination between the cosmids. This system was successfully used to rescue infectious herpes simplex 1 viruses (7), cytomegaloviruses (8) and Epstein-Barr viruses (9) from their respective cosmids.
Positive-Strand RNA Viruses RNA-containing viruses belong to a variety of families with diverse replication strategies. Unique among the RNA viruses are the retroviruses, whose replication involves a doublestranded DNA phase, making these viruses an easy target for genetic manipulation. Transfection of full-length cDNA molecules leads to the establishment of replicating virus particles and integration of the viral genetic information into the host genome (10) . The engineering of retroviral genomes has become one of the most successful genetic approaches in modern virology and is central to the study both of viral gene expression and of protein structure-function analysis. In addition, retrovirus constructs are among the most widely used vectors for gene transfer and gene therapy (11) .
Most of the other positive-strand RNA viruses are also amenable to genetic engineering approaches (Table 1 ). In the case of the small and medium sized positive-strand RNA viruses, full-length genomic RNA has been shown to be infectious when transfected into cells. Plus-strand RNA serves as mRNA for the synthesis of viral proteins as well as template for viral RNA replication. Thus, transfection of cloned DNA of poliovirus RNA (or of cDNA-derived RNA) into permissive cells results in the formation of infectious virus particles (12) .
Remarkably successful have been studies using Sindbis viruses and Semliki forest virus (13, 14) . The cDNA-derived RNAs of these positive-strand RNA viruses can be used to efficiently rescue infectious viruses, thus allowing an extensive analysis of the promoter elements of the viral RNAs as well as structurefunction studies of the viral proteins. Furthermore, these viruses have received increased attention because of their potential for expressing copious amounts of heterologous genes via recombinant constructs. Up to 108 molecules of heterologous protein per cell have been expressed using these systems.t
Introduction of cDNA-Derived RNA into a Negative-Strand RNA Virus (Influenza Virus)
The life cycle of negative-strand RNA viruses differs from that of the other RNA viruses in many ways. Specifically, the genomic RNA of negative-strand RNA viruses is not infectious, and infectious virus particles must also deliver their own RNA-dependent RNA polymerase into the infected cell to start the first round of virus-specific mRNA synthesis.
Thus, approaches different from those used for positivestrand RNA viruses had to be developed to An effective DNA transfection system has also been developed for another rhabdovirus, vesicular stomatitis virus (VSV) (35, 36) (Fig. 3) . Again, the polymerase complex (N, P, and L proteins) was expressed in cells from plasmids transcribed by a T7 RNA polymerase-containing vaccinia virus recombinant. Recombinant VSVs expressing an additional transcriptional unit were rescued and high-expression levels of heterologous proteins were achieved (37) . In a dramatic experiment, the authors were able to construct a recombinant VSV expressing the CD4 protein. This expressing T7 polymerase and the measles N and P proteins has been used for the rescue of infectious virus from full-length clones (38) and vaccinia virus-based systems have allowed the rescue of respiratory syncytial virus (39) and of Sendai viruses (40, 41) .
Most of the earlier systems developed for the nonsegmented viruses used the intracellular expression of antigenomic plussense RNA as the template to initiate the replication cycle. Either the plus-sense RNA was transcribed by the T7 polymerase expressed by a vaccinia-recombinant virus (32, 35, 36, (39) (40) (41) , or transcription was driven by the T7 polymerase which was permanently expressed in cells (38) . Recently, an important series of experiments showed that intracellular expression of a full-length transcript generated infectious Sendai virus regardless of whether the plus-sense or the minus-sense RNA was transcribed (41) . Success appears to have come from fine tuning the system in terms of the concentration of the polymerase components (N, P, and L proteins) and from constructing plasmids giving rise to transcripts with 5' and 3' ends identical to those of the wild-type RNA. Optimization of the system also involved the use of the vaccinia virus inhibitors, cytosine arabinoside and rifampicin. These compounds reduced the cytotoxicity of vaccinia virus and resulted in a dramatic increase of the expression levels of a Sendai virus RNA-like reporter gene. Most interesting was the finding that recovery of infectious Sendai virus was also possible by transfecting naked RNA. The efficiency of recovery appeared to be lower using plus-sense RNA than the genomic minus-sense RNA (41) . The latter results involving the use of naked RNAs extend the earlier findings that transfection of naked model RNAs alone results in the efficient amplification and expression of these minigenes in cells infected with Sendai virus (31), respiratory syncytial virus (42) or parainfluenza virus 3 (43, 44) . In the future, improvements in the transfection systems to generate novel viruses with ease will provide us with even better tools for the study of negativestrand RNA viruses.
Perspective
The ability to genetically alter negative-strand RNA viruses has already enhanced this field of virology and may have a major influence on future developments in vaccines, gene therapy, cancer treatment, and manufacture of biologicals. First, structure-function studies of individual viral genes are now possible in the context of an infectious virus for a number of negative-strand RNA virus families. These Novel viruses expressing foreign genes may serve prophylactically as vaccines, or they may play a role in gene therapy when a transient expression would be beneficial. The latter may be the case in cancer therapy, which could require a targeted infection followed by the induction of a lethal cytopathic effect. Repeated administration of negative-strand RNA viruses may not be feasible in this situation because of the host's immune response. However, the choice of different Finally, the highly efficient expression of viral and foreign proteins via negative-strand RNA virus vectors may have additional biotechnological applications. It is possible that defective RNA constructs could be used for genetic immunization. This form of vaccination would resemble DNA vaccination (46) in that the defective particle would go through many replication rounds and persist without spreading to neighboring cells. Such RNA replicons may have interesting biological properties since the efficiency of infection should be comparable to that of whole viruses. Also, replication competent viral vectors may help in the manufacture of large quantities of biological reagents, since the quantities expressed by negative-sense RNA viruses can be high. It is also possible that purification of expressed proteins could be made easier if they were incorporated into extracellular virus particles.
The solutions to many of the issues discussed here will depend on the continuing success of basic science and the development of novel strategies to study viruses. Our horizons must expand and include the analysis not only of the viruses but also of their interactions with the host cell. Only by continuing to study these fundamental processes may we hope to reap the benefits offered to us by these new opportunities.
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